PPIs and hypomagnesaemia: more common than we thought?

Abstract

Proton pump inhibitors (PPIs) are associated with several well‐documented side‐effects but one emerging adverse effect, hypomagnesaemia, has so far tended to slip under the radar. In a small audit, the author investigated the rates of magnesium supplementation among PPI users, as a potential indicator of hypomagnesaemia. The results suggest this side‐effect could be more common than previously thought.